nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—Sulfamethazine—ALB—melanoma	0.00312	0.283	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—melanoma	0.00305	0.276	CrCbGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCA—melanoma	0.00278	0.00282	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—melanoma	0.00272	0.00275	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLCB4—melanoma	0.00267	0.0027	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL1—melanoma	0.00267	0.0027	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.00261	0.00264	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.00257	0.0026	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—F2R—melanoma	0.00254	0.00257	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1B1—melanoma	0.00254	0.00257	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—HRAS—melanoma	0.00252	0.00254	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2RL1—melanoma	0.0025	0.00253	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—EDNRB—melanoma	0.00246	0.00249	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRAP1—melanoma	0.00245	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYO7A—melanoma	0.00245	0.00248	CbGpPWpGaD
Sulfisoxazole—Sulfamethizole—ALB—melanoma	0.00237	0.214	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM3—melanoma	0.00235	0.00238	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2RL1—melanoma	0.00227	0.0023	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—KISS1—melanoma	0.00223	0.00225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—melanoma	0.00222	0.00225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.0022	0.00223	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00219	0.00222	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCR4—melanoma	0.00219	0.00221	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00217	0.00219	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR1—melanoma	0.00216	0.00218	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—AKR1B10—melanoma	0.00214	0.00217	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM3—melanoma	0.00214	0.00216	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—MC1R—melanoma	0.00213	0.00215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00211	0.00214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TAS2R60—melanoma	0.00208	0.00211	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM1—melanoma	0.00204	0.00206	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR7—melanoma	0.00204	0.00206	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KISS1—melanoma	0.00202	0.00205	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.00198	0.002	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR1—melanoma	0.00196	0.00198	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MC1R—melanoma	0.00193	0.00195	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—melanoma	0.00193	0.00195	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RHOB—melanoma	0.00185	0.00188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR7—melanoma	0.00185	0.00187	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM1—melanoma	0.00185	0.00187	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00178	0.0018	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL8—melanoma	0.00177	0.00179	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR2—melanoma	0.00169	0.00171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RHOB—melanoma	0.00168	0.0017	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—EDN1—melanoma	0.00168	0.00169	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RAC2—melanoma	0.00166	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLCB4—melanoma	0.00158	0.0016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL1—melanoma	0.00158	0.0016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR2—melanoma	0.00153	0.00155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAC2—melanoma	0.00151	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—WNT5A—melanoma	0.00149	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TRRAP—melanoma	0.00148	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CUL3—melanoma	0.00148	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKR1B10—melanoma	0.00144	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2R—melanoma	0.00144	0.00145	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00141	0.00143	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—EDNRB—melanoma	0.00139	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2RL1—melanoma	0.00134	0.00136	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—melanoma	0.00133	0.12	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GAB2—melanoma	0.00131	0.00133	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GNA11—melanoma	0.00131	0.00133	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2R—melanoma	0.0013	0.00132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.00129	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EDNRB—melanoma	0.00126	0.00128	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM3—melanoma	0.00126	0.00128	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR4—melanoma	0.00124	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.00123	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GNAQ—melanoma	0.00122	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KISS1—melanoma	0.0012	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GAB2—melanoma	0.00119	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GNA11—melanoma	0.00119	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.00119	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.00117	0.00119	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.00117	0.00119	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—melanoma	0.00117	0.106	CrCbGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SKI—melanoma	0.00116	0.00117	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR1—melanoma	0.00116	0.00117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.00114	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MC1R—melanoma	0.00114	0.00115	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—melanoma	0.00114	0.00115	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT3—melanoma	0.00113	0.00114	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.00112	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR4—melanoma	0.00112	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GNAQ—melanoma	0.00111	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.00111	0.00112	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.00111	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM1—melanoma	0.00109	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR7—melanoma	0.00109	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SUFU—melanoma	0.00107	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT3—melanoma	0.00102	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.00102	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BCL2L11—melanoma	0.000995	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RHOB—melanoma	0.000995	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HDAC6—melanoma	0.000956	0.000967	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—EDN1—melanoma	0.000947	0.000958	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000945	0.000956	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000943	0.000953	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000932	0.000942	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CSF2—melanoma	0.000926	0.000936	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR2—melanoma	0.000906	0.000916	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL8—melanoma	0.000906	0.000916	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000902	0.000912	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAC2—melanoma	0.000892	0.000901	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCA—melanoma	0.000887	0.000897	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—WNT5A—melanoma	0.000878	0.000887	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFC—melanoma	0.000878	0.000887	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EDN1—melanoma	0.00086	0.00087	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000857	0.000867	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2—melanoma	0.000841	0.00085	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RAC1—melanoma	0.000823	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCA—melanoma	0.000806	0.000815	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAP2K2—melanoma	0.000788	0.000797	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2R—melanoma	0.000771	0.000779	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAC1—melanoma	0.000747	0.000755	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDNRB—melanoma	0.000746	0.000755	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTK2B—melanoma	0.000724	0.000733	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000715	0.000723	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNA11—melanoma	0.000705	0.000713	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GAB2—melanoma	0.000705	0.000713	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FLT1—melanoma	0.000702	0.000709	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—melanoma	0.000695	0.000703	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000669	0.000677	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HDAC2—melanoma	0.000663	0.00067	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FOXO4—melanoma	0.000663	0.00067	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR4—melanoma	0.000663	0.00067	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNAQ—melanoma	0.000655	0.000662	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—melanoma	0.000631	0.000638	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACER3—melanoma	0.00063	0.000637	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SYK—melanoma	0.000616	0.000623	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—melanoma	0.000611	0.000618	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGAV—melanoma	0.000605	0.000611	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT3—melanoma	0.000605	0.000611	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGFR—melanoma	0.000605	0.000611	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGT2B10—melanoma	0.000576	0.000583	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000569	0.000575	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SOCS1—melanoma	0.00056	0.000566	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAP2K1—melanoma	0.000559	0.000565	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—S100B—melanoma	0.000558	0.000565	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—melanoma	0.000555	0.000561	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HS3ST5—melanoma	0.000536	0.000542	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB4—melanoma	0.000534	0.00054	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—melanoma	0.000533	0.000539	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN2B—melanoma	0.000529	0.000535	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD86—melanoma	0.000512	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—melanoma	0.000512	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDN1—melanoma	0.000508	0.000514	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—melanoma	0.000497	0.000502	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF1—melanoma	0.000497	0.000502	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—melanoma	0.000489	0.000495	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—E2F1—melanoma	0.000486	0.000491	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—melanoma	0.000484	0.000489	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFRA—melanoma	0.000481	0.000486	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGB3—melanoma	0.000476	0.000481	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCA—melanoma	0.000476	0.000481	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SPP1—melanoma	0.000467	0.000472	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP2K2—melanoma	0.000465	0.000471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—melanoma	0.000465	0.00047	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—melanoma	0.000444	0.000449	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—melanoma	0.000443	0.000447	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAC1—melanoma	0.000441	0.000446	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000431	0.000436	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—melanoma	0.000423	0.000428	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB4—melanoma	0.000406	0.00041	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—melanoma	0.000405	0.000409	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000398	0.000403	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—melanoma	0.00039	0.000394	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIP4K2A—melanoma	0.000382	0.000386	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC6A11—melanoma	0.000382	0.000386	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—melanoma	0.000381	0.000386	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD80—melanoma	0.000374	0.000378	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—melanoma	0.000373	0.000377	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIT—melanoma	0.000373	0.000377	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—melanoma	0.000373	0.000377	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NRAS—melanoma	0.000373	0.000377	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTAP—melanoma	0.000371	0.000375	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—melanoma	0.000369	0.000373	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000363	0.000367	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK3—melanoma	0.000357	0.000361	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—melanoma	0.00035	0.000354	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—melanoma	0.000341	0.000345	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK1—melanoma	0.00034	0.000344	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—melanoma	0.00034	0.000344	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PHGDH—melanoma	0.000331	0.000335	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LUM—melanoma	0.000331	0.000335	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP2K1—melanoma	0.00033	0.000334	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—melanoma	0.000328	0.000331	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—melanoma	0.000325	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPSE—melanoma	0.000325	0.000328	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—melanoma	0.000321	0.000324	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CUBN—melanoma	0.000319	0.000322	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—melanoma	0.000314	0.000317	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SDHD—melanoma	0.000308	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CSPG4—melanoma	0.000308	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BSG—melanoma	0.000308	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPAM—melanoma	0.000298	0.000301	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—melanoma	0.000295	0.000298	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—melanoma	0.000294	0.000297	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—melanoma	0.00029	0.000293	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—melanoma	0.000286	0.000289	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—melanoma	0.000275	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—melanoma	0.000273	0.000276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1B—melanoma	0.000268	0.000271	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—melanoma	0.000265	0.000268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—melanoma	0.000263	0.000266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—melanoma	0.000262	0.000265	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—melanoma	0.000261	0.000264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—melanoma	0.000256	0.000259	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G6—melanoma	0.000253	0.000256	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNB1—melanoma	0.000253	0.000256	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—melanoma	0.000248	0.000251	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—melanoma	0.000247	0.00025	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—melanoma	0.000247	0.00025	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NFKB1—melanoma	0.000246	0.000248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—melanoma	0.000241	0.000244	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—VCAN—melanoma	0.000228	0.00023	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—melanoma	0.000223	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—melanoma	0.000221	0.000223	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRAS—melanoma	0.00022	0.000223	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000215	0.000218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK3—melanoma	0.000211	0.000213	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000208	0.00021	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—melanoma	0.000205	0.000207	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK1—melanoma	0.000201	0.000203	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—melanoma	0.000201	0.000203	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP17A1—melanoma	0.000192	0.000194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—melanoma	0.00019	0.000192	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000189	0.000191	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000187	0.000189	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GNA11—melanoma	0.000181	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FASN—melanoma	0.000177	0.000179	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC5A5—melanoma	0.000175	0.000176	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—melanoma	0.000174	0.000176	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GNAQ—melanoma	0.000169	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CD44—melanoma	0.000169	0.00017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—melanoma	0.000168	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000165	0.000167	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000164	0.000165	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1B1—melanoma	0.000162	0.000163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—melanoma	0.000161	0.000163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—melanoma	0.000154	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000143	0.000144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—melanoma	0.000142	0.000144	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—melanoma	0.000133	0.000135	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRKCA—melanoma	0.000122	0.000124	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ERCC2—melanoma	0.000121	0.000123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000101	0.000102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—melanoma	9.59e-05	9.7e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARG—melanoma	9.26e-05	9.36e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—melanoma	8.43e-05	8.53e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—melanoma	8.33e-05	8.42e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—melanoma	7.35e-05	7.43e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—melanoma	7.28e-05	7.37e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—melanoma	6.35e-05	6.42e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—melanoma	4.48e-05	4.53e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—melanoma	3.66e-05	3.7e-05	CbGpPWpGaD
